Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_assertion description "[To evaluate the effects of dexloxiglumide, a CCK-1 receptor antagonist, on gastrointestinal transit (GIT) and symptoms in patients with constipation-predominant IBS (C-IBS); and to explore the influence of CCK-1 receptor polymorphisms on gut transit and the pharmacodynamic response to therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_assertion evidence source_evidence_literature NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_assertion SIO_000772 15743365 NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_assertion wasDerivedFrom befree-20140225 NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_assertion wasGeneratedBy ECO_0000203 NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP519225.RAwsvlZAJU8l6lXJEIvITKk4PdIDFO3f9ioB2Yh2bI-mk130_provenance.